Basal Cell Carcinoma, Squamous Cell Carcinoma
Conditions
Keywords
Mohs Surgery
Brief summary
The goal of this study is to determine if relaxation therapy improves patient satisfaction with Mohs micrographic surgery.
Detailed description
Patients are instructed in relaxation techniques. The goal of this study is to determine how relaxation techniques affect the patient's Mohs micrographic surgery experience.
Interventions
BEHAVIORALrelaxation therapy 1
relaxation therapy 1
BEHAVIORALrelaxation therapy 2
relaxation therapy 2
BEHAVIORALrelaxation therapy 3
relaxation therapy 3
Sponsors
Northwestern University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Age 25 and older * Subjects are undergoing micrographic Mohs surgery for facial basal and squamous cell carcinoma. * The subjects are in good health. * The subjects have willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.
Exclusion criteria
* Subjects who have wound healing problems. * Subjects who have had prior Mohs surgery. * Subjects who are smokers. * Subjects who are currently using anticoagulation therapy * Subjects who have a history of bleeding disorders. * Subjects who are unable to understand the protocol or to give informed consent * Subjects with known mental illness or other psychological conditions, such as psychotic disorders, mood disorders, anxiety disorders, cognitive disorders, depression with psychotic features, dissociative disorders. * Subjects who are taking medications that may affect healing such as prednisone, or any immunosuppressants. * Subjects who are immunocompromised. * Subjects who have Diabetes Mellitus or any other condition determined by the PI to affect healing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient anxiety | 1 day |
Secondary
| Measure | Time frame |
|---|---|
| Scar appearance | 12 weeks |
Countries
United States
Outcome results
None listed